Fuzzy Decision of Drug Dosage for Type-1 Human Immunodeficiency Virus Infected Patients

被引:0
|
作者
Fu, Na [1 ,2 ]
Zhang, Wenjie [1 ]
Xie, Xiangpeng [3 ]
机构
[1] Jiangsu Univ, Affiliated Hosp, Zhenjiang 212001, Jiangsu, Peoples R China
[2] Jiangsu Univ, Sch Med, Zhenjiang 212013, Jiangsu, Peoples R China
[3] Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China
关键词
Drug dosage; Fuzzy decision; Human inununodeficiency virus; Clinical care; POPULATION-DYNAMICS; MODEL; HIV; SYSTEMS;
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
The research subject of fuzzy decision of drug dosage for type-1 human immunodeficiency virus(HIV-1) infected patients is discussed by the aid of a existing fuzzy dynamic HIV-1 model. Firstly, by making use of the previous fuzzy modeling method, that intractable nonlinear predator-prey like model is converted to a set of tractable linear sub-models. Then, based on the above tractable sub-models and a kind of sampled-data fuzzy control strategy with a set of decay factors, all the dynamic properties of the fuzzy dynamic HIV-1 model can be acquired by means of high-performance computer simulations. Thirdly, some fuzzy decisions of drug dosage for HIV-1 infected patients are reasoned by consulting the computer simulation results and thus a bank of instructional advices are suggested for clinic care. Finally, some conclusions and future study directions are specifically discussed in the conclusion part.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 50 条
  • [21] VIRUS LOAD IN CHIMPANZEES INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - EFFECT OF PREEXPOSURE VACCINATION
    TENHAAFT, P
    CORNELISSEN, M
    GOUDSMIT, J
    KOORNSTRA, W
    DUBBES, R
    NIPHUIS, H
    PEETERS, M
    THIRIART, C
    BRUCK, C
    HEENEY, JL
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 1015 - 1020
  • [22] AFFINITY OF ANTI-GP41 ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    RADKOWSKI, M
    LASKUS, T
    GOCH, A
    SLUSARCZYK, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (08) : 455 - 458
  • [23] PREVALENCE OF CYTOMEGALO-VIRUS ANTIBODY IN HEMOPHILIACS AND HOMOSEXUALS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    JACKSON, JB
    ERICE, A
    ENGLUND, JA
    EDSON, JR
    BALFOUR, HH
    TRANSFUSION, 1988, 28 (02) : 187 - 189
  • [24] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [25] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ANTIGENEMIA IN CHILDREN
    BORKOWSKY, W
    KRASINSKI, K
    PAUL, D
    HOLZMAN, R
    MOORE, T
    BEBENROTH, D
    LAWRENCE, R
    CHANDWANI, S
    JOURNAL OF PEDIATRICS, 1989, 114 (06): : 940 - 945
  • [26] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [27] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [28] Transgenic models of human immunodeficiency virus type-1
    Klotman, PE
    Notkins, AL
    TRANSGENIC MODELS OF HUMAN VIRAL AND IMMUNOLOGICAL DISEASE, 1996, 206 : 197 - 222
  • [29] Molecular biology of human immunodeficiency virus type-1
    Joshi, S
    Joshi, RL
    TRANSFUSION SCIENCE, 1996, 17 (03): : 351 - 378
  • [30] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22